retatrutide safety trial Promises Big Weight Loss, but Remains a Question starting dose retatrutide clinical trial

FDA has approved an expanded indication for Wegovy (semaglutide 2.4 mg) in adults with noncirrhotic MASH (F2F3), alongside diet and exercise

In common parlance, they are sometimes just called GLP-1 drugs or even referred to by popular brand names (for example, Ozempic has become shorthand for all GLP-1 medications in the public eye

Lee SH, Oe T, Bliar IA: Vitamin C induced decomposition of lipid hydroperoxides to endogenous genotoxins

Fiber adds bulk and expands in the gut, which can create a painful blockage in a digestive system that has already been slowed down by weight-loss medication

In addition, antioxidants that protect the liver from ROS damage and lipid peroxidation may be depleted: GSH, vitamin E, vitamin C and beta-carotene were found to be reduced in the NASH setting (38, 39)